Inify Laboratories AB
AI-powered digital pathology lab providing fast cancer diagnostics for healthcare providers.
INIFY | ST
Overview
Corporate Details
- ISIN(s):
- SE0017486103
- LEI:
- 549300306YYJ3BX3VB98
- Country:
- Sweden
- Address:
- Scheeles väg 3, 171 65 Solna
- Website:
- https://www.inify.com/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
Inify Laboratories AB provides cancer diagnostics through ultramodern laboratory services within pathology. The company operates a fully digital, standardized, and AI-supported workflow designed to optimize diagnostic quality and significantly reduce turnaround times for biopsy results. Initially specializing in prostate cancer diagnostics with its "Inify Prostate" decision support tool, the company has achieved a significant market share in Stockholm and is expanding into other areas, such as gastrointestinal diagnostics. Inify Laboratories serves healthcare providers and is undergoing international expansion, including into the UK market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-28 10:57 |
Report Publication Announcement
Financial calendar
|
English | 690 bytes | ||
| 2025-11-28 10:57 |
Report Publication Announcement
Finansiell kalender
|
Norwegian | 671 bytes | ||
| 2025-11-12 15:09 |
Regulatory Filings
Inify Laboratories - notice of Extraordinary General Meeting on December 4, 202…
|
Norwegian | 319.8 KB | ||
| 2025-11-12 15:09 |
Regulatory Filings
Inify Laboratories - kallelse till extra bolagsstämma 4 december 2025 - Attachm…
|
Norwegian | 248.2 KB | ||
| 2025-11-12 15:09 |
Pre-Annual General Meeting Information
Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025
|
English | 2.6 KB | ||
| 2025-11-12 15:09 |
Pre-Annual General Meeting Information
Inify Laboratories - kallelse till extra bolagsstämma 4 december 2025
|
Swedish | 2.5 KB | ||
| 2025-11-12 15:09 |
Regulatory Filings
Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025
|
English | 319.8 KB | ||
| 2025-11-12 15:09 |
Regulatory Filings
Inify Laboratories – kallelse till extra bolagsstämma 4 december 2025
|
Swedish | 248.2 KB | ||
| 2025-11-12 10:50 |
ISS
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully …
|
Norwegian | 248.2 KB | ||
| 2025-11-12 10:50 |
Share Issue/Capital Change
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully …
|
English | 21.3 KB | ||
| 2025-11-12 10:50 |
ISS
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully …
|
Norwegian | 319.8 KB | ||
| 2025-11-12 10:50 |
Share Issue/Capital Change
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully …
|
English | 21.3 KB | ||
| 2025-11-12 10:50 |
ISS
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully …
|
English | 319.8 KB | ||
| 2025-11-12 10:50 |
ISS
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully …
|
Swedish | 248.2 KB | ||
| 2025-10-29 11:16 |
Quarterly Report
|
Swedish | 1.7 MB |
Automate Your Workflow. Get a real-time feed of all Inify Laboratories AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inify Laboratories AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inify Laboratories AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-29 | Olof Sandén | Other | Buy | 10,000 | 44,800.00 SEK |
| 2025-01-27 | Olof Sandén | Other | Buy | 6,840 | 28,659.60 SEK |
| 2023-07-05 | Magne Jordanger | Other | Buy | 650,000 | 6,500,000.00 EUR |
| 2022-08-19 | Magne Jordanger | Other | Buy | 336,950 | 2,560,820.00 EUR |
Peer Companies
